MIA
GILD icon

Milestone Investment Advisors’s Gilead Sciences GILD Stock Holding History

Milestone Investment Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-214
Closed -$16K – 244
2023
Q3 		$16K Buy
+214
New +$16.5K ﹤0.01% 269
2023
Q2 		– Sell
-214
Closed -$17.8K – 239
2023
Q1 		$17.8K Buy
+214
New +$17.7K 0.01% 271

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Milestone Investment Advisors's GILD Position: Q4 2023 in Review

Milestone Investment Advisors sold out of Gilead Sciences (GILD) in Q4 2023, closing a stake of 214 shares — an estimated $16K sold.

Milestone Investment Advisors first reported a position in GILD in Q1 2023 and held it in 2 quarters. The position peaked at $17.8K in Q1 2023. 1,775 funds tracked by Wall St. Rank hold GILD as of Q4 2023.

  • Milestone Investment Advisors reported no remaining Gilead Sciences position as of Q4 2023 after selling out during the quarter.
  • Milestone Investment Advisors sold 214 Gilead Sciences shares in Q4 2023, an estimated $16K.
  • Milestone Investment Advisors first reported a position in Gilead Sciences in Q1 2023 and held it in 2 quarters.
  • Milestone Investment Advisors's Gilead Sciences position peaked at $17.8K in Q1 2023.
  • 1,775 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2023.

Based on Milestone Investment Advisors's 13F filing for Q4 2023, filed 9 Feb 2024.